Chewy Files Routine 8-K on Jan 18, Confirms NYSE Listing

Ticker: CHWY · Form: 8-K · Filed: 2024-01-18T00:00:00.000Z

Sentiment: neutral

Topics: administrative, corporate-governance, exchange-listing

TL;DR

**Chewy filed a routine 8-K, no new material news for investors.**

AI Summary

Chewy, Inc. filed an 8-K on January 18, 2024, to report an "Other Event" and "Financial Statements and Exhibits." This filing primarily serves to update administrative information, such as confirming its registration on the New York Stock Exchange under the trading symbol CHWY for its Class A Common Stock, par value $0.01 per share. For investors, this filing is largely procedural and does not contain new financial or operational news that would directly impact the stock's valuation, indicating business as usual.

Why It Matters

This filing is a standard administrative update, confirming Chewy's existing stock listing details and providing no new material financial or operational information. It signals business continuity rather than any significant change.

Risk Assessment

Risk Level: low — This 8-K is a standard administrative filing with no new material information that would introduce or mitigate risk.

Analyst Insight

Investors should note this is a routine administrative filing and does not contain new information that would warrant immediate action. Continue to monitor for future filings with material financial or operational updates.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of Chewy, Inc.'s 8-K filing on January 18, 2024?

The 8-K filing by Chewy, Inc. on January 18, 2024, is categorized under 'Other Events' and 'Financial Statements and Exhibits,' primarily serving as a routine administrative update to confirm its registration details, such as its Class A Common Stock being listed on the New York Stock Exchange under the trading symbol CHWY.

What is the trading symbol and exchange for Chewy, Inc.'s Class A Common Stock?

Chewy, Inc.'s Class A Common Stock is registered on the New York Stock Exchange under the trading symbol CHWY, as stated in the filing.

What is the par value of Chewy, Inc.'s Class A Common Stock?

The par value of Chewy, Inc.'s Class A Common Stock is $0.01 per share, according to the filing.

Is Chewy, Inc. considered an 'emerging growth company' based on this filing?

No, the filing indicates with a '☐' that Chewy, Inc. is not an 'emerging growth company' as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

What is Chewy, Inc.'s business address and phone number as listed in the filing?

Chewy, Inc.'s business address is 7700 West Sunrise Boulevard, Plantation, Florida 33322, and its telephone number is (786) 320-7111, as provided in the filing.

Filing Stats: 724 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2024-01-18 16:04:46

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. As previously announced on October 30, 2023, Chewy, Inc. ("Chewy" or the "Company") entered into certain transactions (the "Transactions") with affiliates of BC Partners Advisors LP pursuant to an Agreement and Plan of Merger. The Transactions resulted in, among other things, Chewy Pharmacy KY, LLC ("Chewy Pharmacy KY") becoming an indirect wholly-owned subsidiary of the Company. The Company is filing this Current Report on Form 8-K (this "Form 8-K"), including Exhibit 99.1, which is incorporated herein by reference, solely to recast certain financial information to reflect the operations of Chewy Pharmacy KY as part of its consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended January 30, 2022 originally filed with the U.S. Securities and Exchange Commission (the "SEC") on March 29, 2022 (the "2021 Form 10-K"), the Company's Annual Report on Form 10-K for the fiscal year ended January 29, 2023 originally filed with the SEC on March 22, 2023 (the "2022 Form 10-K") and the Company's Quarterly Reports on Form 10-Q for the quarterly periods ended April 30, 2023, July 30, 2023 and October 29, 2023 originally filed with the SEC on May 31, 2023, August 30, 2023 and December 6, 2023, respectively (collectively, the "2023 Form 10-Qs" and together with the 2021 Form 10-K and 2022 Form 10-K, the "Previous Reports"). The Company has also included in Exhibit 99.1 certain recasted non-GAAP financial measures which reflect the operations of Chewy Pharmacy KY. See "Non-GAAP Financial Measures" in Exhibit 99.1 to this Form 8-K for additional information. The recasted financial information contained in Exhibit 99.1 to this Form 8-K does not represent a restatement of previously issued financial statements. This Form 8-K does not reflect other events occurring after the filing dates of the Previous Reports, except as otherwise reflected in Exhibit 99.1. This Form 8-K should be read in conjunction

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Recasted historical unaudited condensed consolidated financial information of the Company reflecting Chewy Pharmacy KY's operations. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHEWY, INC. Date: January 18, 2024 By: /s/ Stacy Bowman Stacy Bowman Interim Chief Financial Officer and Chief Accounting Officer

View on Read The Filing